ArticleZeitschrift fur Rheumatologie2020

Relative efficacy and safety of tofacitinib, baricitinib, upadacitinib, and filgotinib in comparison to adalimumab in patients with active rheumatoid arthritis.

Young Ho Lee et al.PubMed ↗Publisher ↗

No numbers read from the abstract.